Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 741281000036116 | cobicistat + elvitegravir + emtricitabine + tenofovir (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 741291000036119 | tenofovir + emtricitabine + elvitegravir + cobicistat | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tenofovir + emtricitabine + elvitegravir + cobicistat | has intended active ingredient | emtricitabine | false | Inferred relationship | Some | ||
| tenofovir + emtricitabine + elvitegravir + cobicistat | has intended active ingredient | tenofovir | false | Inferred relationship | Some | ||
| tenofovir + emtricitabine + elvitegravir + cobicistat | has intended active ingredient | elvitegravir | false | Inferred relationship | Some | ||
| tenofovir + emtricitabine + elvitegravir + cobicistat | has intended active ingredient | cobicistat | false | Inferred relationship | Some | ||
| tenofovir + emtricitabine + elvitegravir + cobicistat | Is a | tenofovir + emtricitabine | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | Is a | False | tenofovir + emtricitabine + elvitegravir + cobicistat | Inferred relationship | Some | |
| tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | Is a | False | tenofovir + emtricitabine + elvitegravir + cobicistat | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Concept inactivation indicator reference set
Description inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set
FHIR